What to Expect

Breakthrough T1D is proud to host an event celebrating bold innovation in Type 1 Diabetes research. Startups and early-stage companies aligned with our research strategy will showcase their work across Disease Modifying Therapies, Cell Therapies, Early Detection, and Improving Lives — including immune modulation, beta cell protection and regeneration, advanced cell therapy solutions, next-generation screening and risk assessment tools, and innovations in glucose control, closed-loop devices, and long-term complication therapies. Breakthrough T1D's overall goal is to deliver therapies that prevent the onset of Type 1 Diabetes, restore pre-diabetes physiology in people with established Type 1 Diabetes, and improve everyday life for those living with the condition, and this event highlights the advancements bringing us closer to that vision.

Agenda

4:00 PM: Registration & Networking 
4:30 PM: Welcome Remarks
4:40 PM: Breakthrough T1D Presents: Funding Opportunities & Initiatives

4:45 PM: Finalist Pitches 
5:35 PM: Judges Deliberation & Networking
5:50 PM: Winner Announcement & Award Presentation
7:00 PM: Event Close

Judges

Headshot of Megan Ann Greenfield.

Esther Latres

Senior Vice President, Research at BT1D

Headshot of Maike Scharp.

Alan Chiu

Senior Scientist at BT1D

Headshot of Michael Quirk.

Daniel Flicker

Principal at T1D Fund